Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

June 30, 2026

Conditions
Pulmonary Hypertension
Interventions
DEVICE

Gradient Denervation System

The Gradient Denervation System delivers ultrasound ablation to planned locations in the pulmonary artery to down-regulate the sympathetic nervous drive. The system includes a sterile, single-use catheter that is designed to centrally position the transducer within the arterial target zone for consistency of ablation.

Trial Locations (3)

08916

RECRUITING

Hospital Universitari Germans Trias i Pujol, Badalona

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

Unknown

RECRUITING

Hospital Clínico Universitario de Valencia, Valencia

All Listed Sponsors
lead

Gradient Denervation Technologies

INDUSTRY

NCT06495970 - Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study) | Biotech Hunter | Biotech Hunter